HACKENSACK, N.J. (AP) — HACKENSACK, N.J. (AP) — Protalix BioTherapeutics Inc. (PLX) on Friday reported a loss of $4.6 million in its first quarter.
The Hackensack, New Jersey-based company said it had a loss of 6 cents per share.
The drug developer posted revenue of $3.7 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PLX at https://www.zacks.com/ap/PLX
For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights.
, source Associated Press News